Pfizer Ceo
- All
- News
- Videos
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
EU Chief Slammed For Secret Texts To Pfizer CEO, Ordered To Turn Them In
An official EU watchdog on Friday slammed European Commission chief Ursula von der Leyen for keeping secret text messages with Pfizer's CEO about purchasing Covid vaccine doses, saying it "constituted maladministration".
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer CEO "Not At All" In Favour Of US Patent Waiver: Report
Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.
-
Pfizer In Talks With India Over "Expedited Approval" For COVID-19 Vaccine
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
-
"Strengthen Pandemic Response": Indian Envoy's Meet With Pfizer CEO In US
Indian Ambassador to the USTaranjit Singh Sandhu on Thursday (local time) met with Pfizer CEO Albert Bouria to discuss ways in which the COVID-19 vaccine maker can support healthcare efforts in India.
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Pfizer Head Says Third Vaccine Dose "Likely" Needed Within 12 Months
The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's Covid-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost of the jab.
-
Pfizer Says It Can Deliver 10% More Covid Vaccines By End Of May
Pfizer has "ramped up production" of its Covid-19 vaccine and can deliver 10 percent more doses than expected to the United States by the end of May, its CEO Albert Bourla said on Tuesday.
-
Oxford Vaccine Will Protect 95 Per Cent, Says AstraZeneca CEO: Report
The Oxford coronavirus vaccine will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna" alternatives, Pascal Soriot, the chief executive of AstraZeneca, told British daily The Sunday Times
-
BioNTech CEO Reveals "Biggest Challenge" After Covid Vaccine Gets US Nod
The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand.
-
"UK Marks A Historic Moment In Fight Against Covid-19": Pfizer CEO
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
EU Chief Slammed For Secret Texts To Pfizer CEO, Ordered To Turn Them In
An official EU watchdog on Friday slammed European Commission chief Ursula von der Leyen for keeping secret text messages with Pfizer's CEO about purchasing Covid vaccine doses, saying it "constituted maladministration".
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer CEO "Not At All" In Favour Of US Patent Waiver: Report
Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.
-
Pfizer In Talks With India Over "Expedited Approval" For COVID-19 Vaccine
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
-
"Strengthen Pandemic Response": Indian Envoy's Meet With Pfizer CEO In US
Indian Ambassador to the USTaranjit Singh Sandhu on Thursday (local time) met with Pfizer CEO Albert Bouria to discuss ways in which the COVID-19 vaccine maker can support healthcare efforts in India.
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Pfizer Head Says Third Vaccine Dose "Likely" Needed Within 12 Months
The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's Covid-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost of the jab.
-
Pfizer Says It Can Deliver 10% More Covid Vaccines By End Of May
Pfizer has "ramped up production" of its Covid-19 vaccine and can deliver 10 percent more doses than expected to the United States by the end of May, its CEO Albert Bourla said on Tuesday.
-
Oxford Vaccine Will Protect 95 Per Cent, Says AstraZeneca CEO: Report
The Oxford coronavirus vaccine will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna" alternatives, Pascal Soriot, the chief executive of AstraZeneca, told British daily The Sunday Times
-
BioNTech CEO Reveals "Biggest Challenge" After Covid Vaccine Gets US Nod
The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand.
-
"UK Marks A Historic Moment In Fight Against Covid-19": Pfizer CEO
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
